Learn More
Enzo Life Sciences 17-AAG (1mg). CAS: 75747-14-7

Supplier: Enzo Life Sciences BMLEI3080001
17-AAG is a less toxic and more stable analog of geldanamycin. It is an HSP90 inhibitor that displays a 100-fold higher affinity for HSP90 derived from tumor cells compared to HSP90 from normal cells. 17-AAG inhibits Akt activation and expression in tumors and synergizes with a number of antitumor agents such as taxol, cisplatin, and UCN-014. 17-AAG causes the inactivation, destabilization and eventual degradation of HIF-1α. Inhibitor of telomerase activity. Inducer of apoptosis with antitumor activity. Inducer of macroautophagy. Alternative name: 17-(Allylamino)-17-desmethoxygeldanamycin. Purity: ≥98% (TLC). Solubility: Soluble in DMSO (>20mg/ml) or 100% ethanol (10mg/ml). Long Term Storage: -20°C.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.